REGISTERED
on 02 Mar 2021
Last Applicant/ Owned by
23632 Calabasas Rd, Suite 100
Calabasas
CA
91302
Serial Number
88044977 filed on 19th Jul 2018
Registration Number
6283602 registered on 02th Mar 2021
Correspondent Address
Todd M. Malynn
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
TURN THERAPEUTICS
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharma Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
First Use Date in General
30th Nov 2018
First Use Date in Commerce
30th Nov 2018
Class [005]
Pharmaceutical Products
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for infectious diseases; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes
First Use Date in General
31st Jul 2019
First Use Date in Commerce
31st Jul 2019
Mark Details
Serial Number
No 88044977
Mark Type
No Service Mark
Attorney Docket Number
No 085044611847
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Mar 2021 | REGISTERED-PRINCIPAL REGISTER |
| 28th Jan 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 27th Jan 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 27th Jan 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 25th Jan 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 06th Jan 2021 | USE AMENDMENT FILED |
| 06th Jan 2021 | TEAS STATEMENT OF USE RECEIVED |
| 02th Sep 2020 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 10th Jul 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Jul 2020 | TEAS EXTENSION RECEIVED |